Ninety percent of systemic lupus erythematosus patients are female, and gender differences in lupus susceptibility are also observed in (New Zealand Black Â New Zealand White)F1 (BWF1) lupus-prone mice. We followed orchiectomized, intact male and female BWF1 mice for lupus-like disease for 1 year. A comparative gene expression analysis was then used to identify candidate genes potentially responsible for gender-dependent differences in lupus susceptibility. Seven genes encoded on the sex chromosomes and 77 probe sets, including 14 immunoglobulin genes, encoded on the autosomal chromosomes were identified as differentially expressed in male versus female BWF1 splenocytes prior to disease onset. Five genes were determined to be regulated by either estradiol or dihydrotestosterone in an in vivo system and most of them were preferentially expressed in antigen-presenting cells. Gender differences in the expression of Csf3-r, Histh1c, Serpinb2, Slc6a4 and Cd22 in BWF1 mice are the result of transcriptional modification by sex hormones and warrant further investigation. The identification of candidate genes and their expression patterns in splenocyte sub-populations provide new information regarding the mechanisms by which sex hormones influence the development of mouse lupus.
Introduction
Females comprise 90% of patients with systemic lupus erythematosus, an autoimmune disease characterized by the abnormal production of IgG antinuclear autoantibodies (ANAs). 1 Studies suggest that sex hormones may be largely responsible for the gender difference in lupus susceptibility. For example, epidemiological data indicate that high estrogen levels correlate with increased lupus development. Among patients aged 15-44 years old, the female to male patient ratio is approximately 10:1.
2,3 Additionally, high levels (or more active metabolites) of estrogens and low levels (or less active metabolites) of androgens have been correlated with increased lupus incidence in both male and female patients. 4 Finally, studies have shown an increased risk of developing systemic lupus erythematosus in postmenopausal women who received estrogen hormone replacement therapy. 5, 6 Gender also contributes a significant portion of the risk for developing lupus-like disease in (New Zealand Black Â New Zealand White)F1 (BWF1) mice. Several studies have indicated a protective capacity for androgens and an accelerating role for estrogens in BWF1 mice. [7] [8] [9] [10] [11] [12] [13] One group reported that prepubescent orchiectomy of BWF1 male mice increased the incidence of proteinuria and mortality and accelerated the appearance of ANAs as compared to intact males. 7 In addition, administration of dihydrotestosterone (DHT), a nonaromatizable form of testosterone, to neutered mice was sufficient to reduce disease development compared to that observed in intact male mice, while administration of estradiol-17b (E2) to neutered mice accelerated disease. 8 Studies examining the effects of chemical manipulation of sex hormones in BWF1 mice have also generally supported the hypothesis that androgens inhibit and estrogens intensify lupus. [10] [11] [12] [13] The above studies suggest that gender differences in lupus susceptibility are mediated by sex hormones. These hormones primarily induce biological changes by affecting the transcription of target genes, and estrogen and androgen receptors have been identified in most major immune cell populations. [14] [15] [16] [17] [18] [19] [20] Therefore, we undertook studies in BWF1 mice to confirm the role of sex hormones in lupus susceptibility and to identify genes that are differentially expressed between male and female mice prior to when disease becomes evident. Additional experiments determined which specific immune cells might be affected by such differential expression and whether the candidate genes are regulated by estrogens or androgens. The candidate genes identified in our analysis provide novel insights into the potential mechanisms of gender-specific immune responses and lupus-like disease.
Results
Effect of gender on lupus-like disease traits and splenic immune cell phenotypes of BWF1 male and female mice To extend previously reported gender-specific differences in lupus susceptibility and the potential protective effect of androgens in BWF1 mice, [7] [8] [9] we characterized proteinuria and autoantibody production in intact male and female mice as well as in orchiectomized and shamorchiectomized male animals ( Figure 1 ). While intact and sham-orchiectomized male mice showed a delay in the development of proteinuria, the percentages of orchiectomized male and intact female mice with severe proteinuria progressively increased at 6 months of age and reached 100% at 12 months of age (female versus male, P ¼ 0.0001 and orchiectomized versus shamorchiectomized, P ¼ 0.0005) (Figure 1a) .
Serum levels of IgG autoantibodies to different nuclear antigens were evaluated at 7 months of age in intact male and female mice as well as in orchiectomized and shamorchiectomized male mice (Figure 1b) . BWF1 females exhibited higher levels of IgG anti-histone (P ¼ 0.05), dsDNA (double-stranded DNA) (P ¼ 0.004), ssDNA (single-stranded DNA) (P ¼ 0.03) and chromatin (P ¼ 0.008) than male mice at this age (Figure 1b) . Similarly, orchiectomized male mice tended to exhibit higher levels of IgG anti-chromatin and anti-ssDNA and developed significantly higher levels of IgG anti-histone and dsDNA autoantibodies than intact BWF1 male mice (P ¼ 0.008 and P ¼ 0.02, respectively). Orchiectomized mice produced higher quantities of IgG anti-histone and chromatin (P ¼ 0.02 for both), but not IgG anti-dsDNA or ssDNA, than sham-orchiectomized mice. The increased group mean levels of IgG anti-dsDNA and ssDNA in sham-orchiectomized mice compared to intact male mice appeared to be related to high levels in two mice. As expected, IgG ANAs were undetectable in the serum of B6 control mice.
Serum levels of total IgM and IgG were also measured in BWF1 male and female mice at 4 and 5 months of age ( Figure 1c) . Total serum levels of IgM and IgG were similar in male and female mice at 4 months of age, but at 5 months of age immunoglobulin (Ig) levels increased more dramatically in female mice (Figure 1c) .
To compare cellular phenotypes and gene expression between male and female mice, spleens were harvested from 4-month-old animals. Spleens from female mice yielded a larger number of cells than spleens from male mice (8.5 Â 10 7 versus 6.7 Â 10
7
; P ¼ 0.01) (Figure 2a ). The increased spleen size was not due to expansion of one particular cell type, since the percentages of B cells, T cells and dendritic cells (DCs) were similar in male and female mice (Figure 2a) .
We evaluated the expression of the cell surface molecules CD80, CD86 and major histocompatibility complex class II on DCs and B cells (Figure 2b and data not shown). Splenic DCs and B cells from BWF1 female mice express CD80 at a slightly higher density per cell than DCs from male mice (P ¼ 0.03), although there was considerable overlap in mean florescence intensity between the two groups. It should be noted that the difference in CD80 expression between male and female CD11c þ cells was noted in both CD11b þ CD11c þ and CD11bÀ CD11c þ subsets, of which there were roughly equal percentages (data not shown). The ex vivo expression of CD86 and major histocompatibility complex class II was similar on splenic DCs from BWF1 male and female mice (data not shown).
The percentages of activated and regulatory CD4 þ T cells were also assessed in BWF1 male and female mice (Figure 2b ). Although overall differences were not statistically significant, several females tended to have a higher percentage of CD4 þ T cells expressing CD44 as well as cells expressing CD25 and low levels of CD62L than male mice. Analysis of a larger number of mice may clarify this issue. Male and female mice had approximately equivalent populations of CD4 þ regulatory T cells expressing CD25 and high levels of CD62L. , orchiectomized (n ¼ 9), sham-orchiectomized (n ¼ 9) and intact male (n ¼ 15) mice were tested monthly for proteinuria. (b) Serum samples from 7-month-old female, orchiectomized, sham-orchiectomized and intact male mice were analyzed for IgG autoantibodies to histone, ssDNA, chromatin and dsDNA. Sera from non-lupus prone B6 mice were included as negative controls. (c) Mean levels ( ± s.d.) of total IgM and IgG were assessed in the sera from BWF1 male (n ¼ 12) and female mice (n ¼ 14) at the time points indicated. dsDNA, double-stranded DNA; ssDNA, single-stranded DNA.
Furthermore, there were no differences in the levels of Foxp3 mRNA in the spleen between the two groups.
Identification of genes differentially expressed in male versus female mice To identify candidate genes that might be involved in the development of disease in female versus male mice, with minimal disease-dependent secondary influences, we compared gene expression profiles of spleen samples obtained from 4-month-old mice. Previous studies indicate that 4-month-old mice do not have clinical evidence of renal disease (MR Gubbels Bupp and BL Kotzin, unpublished observations), and the levels of IgG ANA are minimally detectable at this age. We hypothesized that splenic tissue was likely to contain disease relevant sex hormone-regulated transcripts since spleen has been shown to be a major site of IgG autoantibody production, 21, 22 and differences in autoantibody production appear to mark the first detectable stage in lupus pathogenesis sensitive to the effects of sex hormones. We expected differentially expressed genes to fall into three categories: (1) genes encoded on the Y chromosome, (2) genes encoded on the X chromosome that escape X-inactivation and (3) genes encoded on the autosomes that are potentially regulated by sex hormones. Criteria for differential expression were determined before analyzing any data set and were comprised of a consistency measure, a quantity measure and a statistical measure.
Overall, 13 684 probe sets were expressed in BWF1 splenic samples. Seven unique probe sets encoded on the sex chromosomes and 77 encoded on the autosomes were identified as differentially expressed in male versus female samples (original data deposited in NCBI's GEO series; accession number GSE2336). Thirty-four probe sets represented genes, 29 represented expressed sequence tags (ESTs) and 14 were Ig genes. Probe sets corresponding to autosomal ESTs were not considered further because their potential biological functions are unknown.
Seven genes encoded on the X or Y chromosomes were detected as differentially expressed between BWF1 male and female mice (Figure 3 ). The fold changes and consistency scores for this category of genes were very high, with most genes demonstrating a fold change of 50 and a consistency score of 16, as one would expect for genes expressed exclusively in one gender. For example, Xist, a silencing transcript expressed exclusively from the inactive X chromosome, was greatly overexpressed in females in 16 out of 16 pairwise comparisons.
Thirty-four genes encoded on the autosomes were detected as differentially expressed in samples obtained Figure 3 Differentially expressed genes between BWF1 male and female mice that are encoded on the sex chromosomes. A comparative gene expression analysis was conducted on splenic RNA from 4-month-old BWF1 male (n ¼ 4) and female (n ¼ 4) mice. Three genes encoded on the X chromosome that escape X inactivation (solid bars) were detected in spleen and were upregulated in BWF1 female mice (Xist, inactive X-specific transcript; Eif2s3x, eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked; Utx, ubiquitously transcribed tetratricopeptide repeat gene, X chromosome). Four genes encoded on the Y chromosome (striped bars) were detected in spleen and were upregulated in BWF1 male mice (Uty, ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome; Jarid1d, jumonji, ATrich interactive domain 1D; Eif2s3y, eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked; Ddx3Y, DEAD (AspGlu-Ala-Asp) box polypeptide 3, Y-linked). One EST (expressed sequence tag) of the 9 ESTs or pseudogenes mapped to the Y chromosome and analyzed in this study was also found to be differentially expressed. Unexpectedly, 14 Ig genes were upregulated in BWF1 male mice by approximately twofold, although all were expressed in female mice (data not shown). This was surprising since female BWF1 mice expressed slightly higher levels of serum IgG at this age (see Figure 1c) , and no Ig genes analyzed were increased in female versus male mice. Eleven of the genes were k lightchain sequences that shared considerable sequence similarity in both the framework and complementaritydetermining regions. Of the k light-chain sequences, two may represent non-mutated germline sequences (X82691 and AF029261). Three sequences did not overlap with other differentially expressed Ig sequences: an aberrantly rearranged k chain gene (K03461) and two heavy-chain genes (J00475 and AF000913). One heavy-chain sequence (J00475) included both the variable and constant region of IgA, and the other sequence (AF000913) represented the germline heavy-chain variable region. Figure 4 Candidate genes encoded on the autosomal chromosomes. A comparative gene expression analysis was conducted as described in the text. Genes were grouped by function. (Csf3-r, colony-stimulating factor 3 receptor; Icosl, inducible T-cell co-stimulator ligand; Cd37, CD37 antigen; Cd22, CD22 antigen; Clec1b, C-type lectin domain family 1, member b; Zfp36l2, zinc-finger protein 36, C3H type-like 2; Hnrpl, heterogeneous nuclear ribonucleoprotein L; Sept1, septin 1; Serpinb2, serine (or cysteine) peptidase inhibitor, clade B, member 2; Tgfb-1, transforming growth factor, beta 1; Trp53, transformation-related protein 53; Hmox1, heme oxygenase (decycling) 1; Rara, retinoic acid receptor alpha; Aes, amino-terminal enhancer of split; Crebl1, cAMP responsive element-binding protein-like 1; Rab10, RAB10, member RAS oncogene family; Arhgef1, Rho guanine nucleotide exchange factor 1; Rsu1, Ras suppressor protein 1; Anxa11, annexin A11; Edg6, endothelial differentiation, G-protein-coupled receptor 6; Arpc4, actin-related protein 2/3 complex, subunit 4; Itga8, integrin alpha 8; Fmnl1, formin-like 1; Fbln5, fibulin 5; Oprs1, opioid receptor, sigma 1; H2-Dmb2/1; histocompatibility 2, class II, locus Mb2/Mb2; Alox12, arachidonate 12-lipoxygenase; Scd1, stearoyl-coenzyme A desaturase 1; Pon3, paraoxonase 3; Slc6a4, solute carrier family 6 (neurotransmitter transporter, serotonin), member 4; Evi2, mouse ecotropic viral integration site 2; B4galnt1, beta-1,4-N-acetyl-galactosaminyl transferase 1; Hist1h1c, histone cluster 1, h1c).
Expression analysis of candidate genes by quantitative Taqman PCR
The expression of 26 (25 genes plus the 3-member Zfp36l2 probe set) out of the 34 gene probe sets encoded on the autosomes identified to be differentially expressed between BWF1 male and female mice by microarray was assessed in a larger group of mice by qRT-PCR (Figure 5a ). Eleven genes were verified to be differentially expressed by qRT-PCR and three genes showed a trend for differential expression. Fold changes identified by qRT-PCR were always in the same direction as fold changes identified by microarray analysis, even when expression differences did not reach statistical significance and overall, fold changes identified by microarray were of similar magnitude as those verified by qRT-PCR. For instance, arachidonate 12-lipoxygenase (Alox12), an enzyme involved in the conversion of arachidonate to inflammation-promoting leukotriene lipids, was represented approximately twofold more in female mRNA samples as compared to male samples in both analyses.
The expression of select candidate genes verified to be differentially expressed (Figure 5a ) and with subsequent The cellular expression patterns of candidate genes verified to be differentially expressed by quantitative PCR and subsequently shown to be regulated by sex hormones (including three genes that showed a trend for hormone regulation) were evaluated. mRNA levels of Csf3-r, CD22, Serpinb2, Rara, Rsu1, Alox12, Slc6a4 and Histh1c in B cells, T cells, macrophages and dendritic cells (DCs) sorted from both male and female BWF1 spleens were assessed by quantitative (real-time) PCR and normalized to levels of b2 microglobulin mRNA. Figure 6 Sex hormone regulation of candidate genes determined to be differentially expressed between BWF1 male and female mice by microarray and quantitative real-time-PCR. Total splenic RNA was harvested from BWF1 male mice that had been orchiectomized at 3 months of age and implanted with pellets releasing either dihydrotestosterone (DHT) (solid gray bars, n ¼ 7), estradiol-17b (estradiol) (cross hatched bars, n ¼ 9) or placebo (solid black bars, n ¼ 8) for 21 days. Quantitative PCR was performed to assess mRNA levels of 15 candidate genes. All expression levels were normalized to levels of b2 microglobulin mRNA. *Po0.02, (Figure 6 ) was assessed in particular splenocyte sub-populations (Figure 5b) . Notably, five out of eight genes were predominantly expressed in antigen-presenting cells (that is, B cells, DCs and macrophages) and none of the genes were selectively expressed in T cells. Colonystimulating factor 3-receptor (Csf3-r) was primarily expressed in macrophages, but was also expressed in B cells and DCs to a small degree. CD22 antigen (Cd22), serine proteinase inhibitor (Serpinb2)
Sex hormone regulation of candidate genes
We were especially interested to identify the candidate genes that are regulated by either androgens or estrogens. Male BWF1 mice were orchiectomized at 3 months of age, and pellets releasing a continuous dose of E2, DHT or placebo were inserted. After 21 days of treatment, spleens were isolated and gene expression was quantified by qRT-PCR ( Figure 6 ). We found that Csf3-r was upregulated in orchiectomized mice treated with DHT as compared to mice treated with E2 or placebo. Cd22 was downregulated in mice treated with E2, while Serpinb2 and Slc6a4 were upregulated by E2. Hist1h1c was upregulated in mice treated with both E2 and DHT, but E2 treatment increased expression of Hist1h1c to a larger extent. Although not statistically significant, three additional genes (Rara, Rsu1 and Alox 12) showed trends for regulation by E2, whereas changes in expression due to E2 or DHT were not apparent for the other genes tested. It should be noted that the in vivo nature of this experiment precludes determination of whether transcription of the candidate genes is directly controlled by E2 or DHT or whether their expression is altered by other more downstream effects of sex hormones.
Discussion
The work described herein was designed to identify sex hormone-regulated candidate genes that may underlie gender-dependent differences in lupus development. We confirmed previous reports indicating that BWF1 female mice develop an accelerated disease course involving IgG ANAs and glomerulonephritis compared to male mice. Female mice also exhibited increased spleen size compared to male mice, but similar percentages of the major immune cell sub-populations. A comparative gene expression study identified a relatively short list of differentially expressed genes in female versus male spleen samples, including 7 genes encoded on the sex chromosomes, 14 Ig genes and 34 non-Ig genes encoded on the autosomes. Surprisingly, the 14 Ig genes were all overexpressed in male mice. Of the 11 differentially expressed non-Ig autosomal genes that were confirmed by quantitative PCR, five were suggested to be under the transcriptional control of E2 and/or DHT in an in vivo system of hormonal manipulation. Interestingly, most of these E2/DHT-regulated candidate genes were primarily expressed in cells with antigen-presentation capabilities.
Sex hormones may intersect with lupus pathogenesis to influence the initial break in B-and T-cell tolerance, the quality and/or quantity of the resulting antibody response, and/or the end-organ inflammatory reaction. 23 Although it is possible that testosterone may impact later disease stages, 24 most studies suggest that sex hormones have the greatest impact on early disease events. For example, previous reports indicated that IgG anti-polyA and dsDNA autoantibodies are produced to greater extents in BWF1 female mice as compared to male mice and that quantities of these autoantibodies are sensitive to hormone manipulation. 8 In addition, estrogen treatment has been reported to impair negative selection of autoreactive B cells within the bone marrow and spleen in mice transgenic for the heavy chain of an anti-dsDNAspecific antibody. 25, 26 In our studies, the delay in the development of proteinuria in BWF1 male mice was preceded by a similar delay in IgG anti-chromatin autoantibody production (MR Gubbels Bupp and BL Kotzin, unpublished data). Moreover, regardless of gender or hormone manipulation, animals exhibiting high levels of IgG ANA went on to develop severe proteinuria characterized by pathologic kidney alterations and large deposits of IgG and C3 (MR Gubbels Bupp and BL Kotzin, unpublished data). Thus, we hypothesize that after B cells have switched to producing IgG autoantibodies, lupus pathogenesis proceeds similarly in male and female mice.
It seemed reasonable that comparison of BWF1 female and male gene expression profiles would yield a relatively short list of differentially expressed genes because the two groups are genetically identical (except for the sex chromosomes) and as discussed above, the tissue and time point for our studies were chosen to limit secondary effects of the disease. Indeed, of the 13 684 sequences expressed in spleen, only 87 were identified as differentially expressed in female versus male splenic samples. The identification of genes encoded on the Y chromosome or those that escape X inactivation as differentially expressed was used to assess the completeness of our analysis, and the results suggested that nearly all of the expected expression differences were detected. All of the genes that are expressed in BWF1 spleens (that is, Eif2s3x, Xist and Utx) and escape X inactivation were identified as overexpressed in female samples. Additionally, four of the five genes expressed in BWF1 spleens and encoded on the Y chromosome (that is, Uty, Jarid1d, Eif2s3Y and Ddx3Y) were shown to be upregulated in male samples. The probe set representing Zfy-2 was not designed to distinguish between Zfy-2 and its homologs on chromosomes X and 10. 27 The analysis also detected one out of nine probe sets corresponding to ESTs and pseudogenes as overexpressed in male samples. The EST probe set detected as differentially expressed was subsequently determined to be redundant for a probe set representing the gene Ddx3Y. Although it is unclear why the analysis did not detect the differential expression of other pseudogenes and ESTs that map to the Y chromosome, it is possible that the probe sets detecting them were not entirely Y-chromosome sequence specific.
It is remarkable that we found 14 differentially expressed Ig genes that were all upregulated in BWF1 male mice, particularly because, at 4 months of age, total IgG and IgM levels were slightly higher in BWF1 female mice and subsequent autoantibody production is delayed in male mice. Each of the Ig genes was expressed in female mice, so it is unlikely that the differentially expressed Ig sequences represent a unique antibody repertoire in BWF1 male mice. An alternative possibility is that the Ig genes more highly expressed in male samples represent an increased population of natural germline autoantibodies, which typically demonstrate low, but broad affinities to self and foreign antigens. 28 It has been hypothesized that natural antibodies may protect from lupus-like autoimmune disease, perhaps by binding to auto-antigens and promoting their removal through complement activation. 28, 29 Given the considerable influence androgens impart on lupus pathogenesis in BWF1 mice, it is somewhat surprising that our analyses identified only two DHTregulated genes. Importantly, the relatively short-term (21 day) system involving hormone pellets after castration in 3-month-old mice may not have recapitulated the influence of androgens versus estrogens from birth to 4 months in intact male mice. It is also possible that the effects of androgens on the immune system are mediated through plasma membrane-bound receptors that may not directly affect gene transcription. 30 Alternatively, androgens may be indirectly inhibiting autoimmune processes by affecting transcription in non-immune cells or at other time points. Still, Csf3-r and Histhlc were identified as candidate genes that may contribute to androgen-mediated inhibition of lupus. DHT-regulated increased expression of Csf3-r, the receptor for granulocyte colony-stimulating factor, may indicate that cells in male mice are more sensitive to Th2 polarizing granulocyte colony-stimulating factor signals than cells from female mice, given that the use of granulocyte colony-stimulating factor in bone marrow transplant patients has been associated with increased numbers of Th2-type polarized DCs and T cells. 31, 32 We also found that both DHT and E2 regulate the expression of Hist1h1c. The protein product of Hist1h1c binds linker DNA between nucleosomes to facilitate the condensation of chromatin into higher ordered structures that may modify the accessibility of transcriptional regulators to target DNA sequences. 33 The upregulation of Hist1h1c by E2 over levels induced by DHT may differentially impact the transcription of other genes that are involved in lupus disease.
Although our results indicate that androgens alone can explain the difference in disease development between BWF1 male and female mice, previous studies of BWF1 mice and human systemic lupus erythematosus have shown that estrogens may also enhance disease development. [2] [3] [4] 34, 35 For example, administration of E2 to orchiectomized BWF1 recipients accelerated lupus-like disease. 8, 36 Additionally, we found that E2 treatment in orchiectomized male mice was sufficient to increase spleen size compared to mice treated with placebo or DHT (MR Gubbels Bupp and BL Kotzin, unpublished observations). Thus, the E2-regulated genes identified in our analyses may mediate gender-dependent differences in immune function and susceptibility to lupus-like disease. In particular, E2 regulation of genes with known roles in apoptosis, such as Serpinb2, may contribute to the increased spleen size we observed in BWF1 female mice. 37 In addition, E2-mediated upregulation of the membrane-bound serotonin transporter, Slc6a4, could potentially influence the availability of auto-antigens. Serotonin has been shown to regulate macrophage function, and macrophage clearance of apoptotic debris containing auto-antigens has been suggested to contribute to lupus pathogenesis. 38, 39 Finally, we demonstrated that E2 downregulates expression of CD22 (encoded by Cd22), an inhibitory receptor on B cells that attenuates Ca 2 þ levels induced after B-cell receptor signaling. 40 Considerable evidence supports the hypothesis that depressed levels of CD22 on B cells can promote IgG ANA production. [41] [42] [43] In contrast to our results, Grimaldi et al. 44 found that mRNA and surface protein expression of Cd22 were upregulated in response to E2 in BALB/c mice and proposed that this upregulation may be involved in the escape of autoreactive B cells from tolerance. Differences in the dose of E2 used or the genetic background of the mice may have contributed to this discordance.
In conclusion, these studies demonstrate that androgens are an important contributor to the delayed development of lupus-like disease in BWF1 male mice. DHT-and E2-regulated genes expressed in immune cells from BWF1 male and female mice are candidate genes that may contribute to gender-dependent lupus phenotypes. Therapeutics that target pathways affected by sex hormones may be useful in a large population of lupus patients and may also translate to other autoimmune diseases associated with increased female incidence.
Materials and methods
Mice BWF1 mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and housed in the animal care facility at the University of Colorado Health Sciences Center (Denver, CO, USA) in accordance with Animal Care and Use Committee guidelines.
Measurement of proteinuria, IgG autoantibodies and total serum Ig levels. Proteinuria was measured using tetracholorophenol-tetrabromosulfophthalein paper (Chemstrip) (Roche Diagnostics, Indianapolis, IN, USA) as described. 45 Levels of serum autoantibodies and total IgM and IgG antibodies were determined by enzymelinked immunosorbent assays (ELISA) as described. 45 Orchiectomy. BWF1 mice were orchiectomized at 2-3 weeks (longitudinal studies on renal disease development) or 3 months of age (qRT-PCR studies). Mice were anesthetized with avertin (200 mg kg
À1
). The vas deferens and testicular artery were sutured before removing the testes and epididymis. Incisions made in anesthetized sham-orchiectomized males were sutured closed without additional manipulation.
Sex hormone treatment
Pellets (Innovative Research of America, Sarasota, FL, USA) containing DHT, E2 or placebo (P) were inserted subcutaneously with a 10-gauge trochar in BWF1 males directly after the surgical procedure. Serum was collected on day 7, 8 or 9 and then analyzed by the Endocrine Laboratory at Colorado State University (Fort Collins, CO, USA) for luteinizing hormone (LH), estradiol and testosterone by radioimmunoassay. Radioimmunoassays are based on the competitive binding of serum hormone and a radiolabeled hormone preparation to an antibody specific for each particular hormone. Briefly, the antibody-bound radiolabeled hormone was separated and the quantity determined by counting in a gamma spectrometer. Results for the unknown were read from a curve prepared by plotting results for a set of known standards. Sera with predetermined concentrations were included in every assay for quality control purposes.
Physiological estradiol levels in mouse serum have been reported to range from 14 to 104 pg ml À1 depending on the estrous cycle and age of the mouse. 
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Orchiectomized BWF1 male mice treated with E2 pellets exhibited serum E2 levels near this range (162 pg ml
À1
), while levels in placebo-treated mice were not detectable (data not shown). Sera from orchiectomized mice treated with DHT were analyzed for LH, since androgens inhibit LH secretion and assays to specifically detect DHT directly are not readily available. Intact and orchiectomized mice treated with DHT had similarly low LH levels (less than 1 ng ml À1 ), while orchiectomized mice treated with placebo had over 20 ng ml À1 of LH (data not shown). Orchiectomized male mice treated with placebo demonstrated testosterone levels less than 2 ng ml À1 , while intact BWF1 male mice exhibited 12 ng ml À1 of testosterone.
Staining and flow cytometry Splenocytes were cleared of red blood cells by osmotic lysis and then incubated with an Fc-receptor-blocking reagent (2.4G2; BD Pharmingen, San Diego, CA, USA) and various combinations of staining antibodies. Antibodies used in these studies were directed to CD3 (17A2; eBioscience, San Diego, CA, USA), B220 (RA3-6B2; BD Pharmingen), CD11c (HL3; eBioscience), CD86 (GL-1; BD Pharmingen), CD80 (16-10A1; BD Pharmingen), IAd (M5/114.15.2; eBioscience), CD44 (IM7; BD Pharmingen), CD25 (7D4; BD Pharmingen) and CD62L (MEL-14; BD Pharmingen). Data were obtained on a FACSCalibur (Becton Dickinson, Bedford, MA, USA) and analyzed with CellQuest (Becton Dickinson) software.
Microarray
Oligonucleotide microarrays (MGU74v2 A, B and C GeneChip probe arrays; Affymetrix, Santa Clara, CA, USA) were hybridized with labeled splenic cRNA from individual BWF1 male and female mice as described in the Affymetrix Expression Analysis Technical Manual. Data were analyzed using GeneChip 3.1 Software (Affymetrix). Each of the four samples obtained from male mice were compared to each of the four samples obtained from female mice such that 16 pairwise comparisons were made. Genes selected as differentially expressed demonstrated change calls in the same direction (increased or decreased) in at least 12 out of 16 possible pairwise comparisons, average fold changes greater than 1.5 and average change P-values less than 0.025. The data discussed in this publication have been deposited in NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO series accession number GSE2336.
Cell separation for quantitative (real-time) PCR analysis Splenocytes from 4-month-old BWF1 mice were incubated with mAbs to B220, CD90 (30-H12; BD Pharmingen), CD11b (M1/70; BD Pharmingen) and CD11c. After washing, cells were sorted on the MoFlo FACS (Dako Cytomation, Glostrup, Denmark) by gating on B220 þ (B cells), CD90
þ (T cells), CD11c hi and CD11c int (DCs) and CD11c À CD11b þ (macrophages). Sorted cell populations were 492% pure.
Quantitative (real-time) PCR After DNase treatment, RNA was subjected to RT-PCR using the SuperScript III Platinum Taq One Step qRT-PCR System (Invitrogen, Carlsbad, CA, USA) and GeneAmp 5700 Sequence Detection system (PE Applied Biosystems, Foster City, CA, USA). mRNA levels of each candidate gene were normalized to mRNA levels of b2 microglobulin to ensure equal RNA input. b2 microglobulin was chosen as a normalizing gene because the mRNA levels of b2 microglobulin did not vary in male versus female mice or with any of the experimental conditions (data not shown). The sequences of forward (F) and reverse (R) primers and probes are shown in Table 1 .
Statistical analysis
The statistical significance of differences between groups of mice was determined using the nonparametric Mann-Whitney U-test or Student's t-test. Statistics used in the microarray analysis are discussed in the microarray section.
